Archivi tag: Terapia del dolore

Scrambler Therapy la risposta immediata contro il dolore cronico

Pubblicazione su PUB MED: Scrambler therapy efficacy

Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheralneuropathy in adolescents: A preliminarystudy.

Author information

1. Anaesthesia and Intensive Care Department, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy.
2. Haematology Oncology Department, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy.
3. Scientific Direction, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy.
4. Pediatric Emergency Department, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy.

Abstract

PURPOSE:

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy, in need of effective treatment. Preliminary data support the efficacy of scrambler therapy (ST), a noninvasive cutaneous electrostimulation device, in adults with CIPN. We test the efficacy, safety, and durability of ST for neuropathic pain in adolescents with CIPN.

PATIENTS AND METHODS:

We studied nine pediatric patients with cancer and CIPN who received ST for paincontrol. Each patient received 45-min daily sessions for 10 consecutive days as a first step, but some of them required additional treatment.

RESULTS:

Pain significantly improved comparing Numeric Rate Scale after 10 days of ST (9.22 ± 0.83 vs. 2.33 ± 2.34; P < 0.001) and at the end of the optimized cycle (EOC) (9.22 ± 0.83 vs. 0.11 ± 0.33, P < 0.001). The improvement in quality of life was significantly reached on pain interference with general activity (8.67 ± 1.66 vs. 3.33 ± 2.12, P < 0.0001), mood (8.33 ± 3.32 vs. 2.78 ± 2.82, P < 0.0005), walking ability (10.00 vs. 2.78 ± 1.22, P < 0.0001), sleep (7.56 ± 2.24 vs. 2.67 ± 1.41, P < 0.001), and relations with people (7.89 ± 2.03 vs. 2.11 ± 2.03, P < 0.0002; Lansky score 26.7 ± 13.2 vs. 10 days of ST 57.8 ± 13.9, P < 0.001; 26.7 ± 13.2 vs. EOC 71.1 ± 16.2, P < 0.001).

CONCLUSION:

Based on these preliminary data, ST could be a good choice for adolescents with CIPN for whom pain control is difficult. ST caused total relief or dramatic reduction in CIPN pain and an improvement in quality of life, durable in follow-up. It caused no detected side effects, and can be retrained successfully. Further larger studies should be performed to confirm our promising preliminary data in pediatric patients with cancer.

Pubblicazione su PUB MED: Scrambler therapy efficacy ultima modifica: 2018-04-17T10:22:00+00:00 da Paolo Borsatti
Scrambler Therapy la risposta immediata contro il dolore cronico

Scrambler Therapy for the treatment of a neuropathic pain related to leukaemia in a pediatric patient: a case report.

Park HS1, Kim WJ, Kim HG, Yoo SH.
1 Department of Anesthesiology and Pain Medicine, School of Medicine, Ewha Womans University, Ewha Womans University Mokdong Hospital, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, Republic of Korea.Abstract

RATIONALE:

Cancer-related neuropathic pain often responds poorly to standard pain treatments. Scrambler therapy has relieved refractory chronic pain in several uncontrolled clinical trials.

PATIENT CONCERNS:

An 11-year-old female patient was suffering from left groin and medial thigh pain after irradiation to the knee. The girl was diagnosed with precursor B-cell lymphoblastic leukemia 2 years ago. Extramedullary relapse of leukemia developed 1 month ago and pain had started. She was treated with oral medications, but she was continuously complaining of severe pain.

DIAGNOSIS:

Neuropathic pain caused by obturator nerve involvement in leukemia.

INTERVENTION:

Scrambler therapy.

OUTCOME:

Pain reduction.

LESSONS:

Scrambler therapy is noninvasive, is not associated with any complications, causes minimal discomfort during treatment, and is very effective in a pediatric patient with cancer-related neuropathic pain.

Scarica il pdf della pubblicazione.

Scrambler Therapy for the treatment of a neuropathic pain related to leukaemia in a pediatric patient: a case report. ultima modifica: 2018-02-07T09:43:19+00:00 da Paolo Borsatti
Scrambler Therapy la risposta immediata contro il dolore cronico

Scrambler Therapy for the Treatment of Chronic Post-Mastectomy Pain (cPMP)

Author information

Smith T1, Cheville AL2, Loprinzi CL3, Longo-Schoberlein D1.

1 Palliative Medicine Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
2 Physical Medicine and Rehabilitation, Mayo Clinic and Foundation, Rochester, MN, USA.
3 Medical Oncology, Mayo Clinic and Foundation, Rochester, MN, USA.

Abstract

Chronic post-mastectomy pain (cPMP), including post-lumpectomy pain, is common with no established ways of treatment. We treated three consecutive patients referred with cPMP with Scrambler therapy (ST), a non-invasive electrical neurocutaneous stimulation. Treatment was given across the area of pain following the dermatomes for 45 minutes daily, for several consecutive days until relief, and then was repeated as needed. The ST MC5A device synthesizes 16 different waveforms that resemble action potentials, delivered to the surface receptors of the c-fibers, to send “non-pain” information along the damaged pathways to reduce central sensitization. All three had marked (over 75%) and sustained (months) reduction of allodynia, hyperalgesia, and pain. All reported marked improvements in their quality of life and normal function. One woman was able to stop chronic opioid use. No side effects were observed. Scrambler therapy is a promising way to relieve cancer and other types of neuropathic pain, and may be helpful in cPMP. Further prospective trials are warranted.

MTS Medical Technology Solutions è rivenditore autorizzato Scrambler Therapy. Per approfondimenti riguardanti pubblicazioni scientifiche, centri in Italia in cui è utilizzata la Scrambler Therapy, condizioni economiche e finanziamenti vi inviamo a contattarci

Scrambler Therapy for the Treatment of Chronic Post-Mastectomy Pain (cPMP) ultima modifica: 2018-01-25T10:51:55+00:00 da Paolo Borsatti
Congresso SICP 2017

XXIV Congresso nazionale Società Italiana di Cure Palliative

Dal 15 al 18 novembre 2017 avrà luogo a Riccione, presso il Palazzo dei Congressi, il XXIV Congresso della Società Italiana di Cure Palliative. Il tema sarà “IL VALORE DELLE SCELTE“.

Tutte le informazioni più importanti le si possono trovare al seguente link

Naturalmente sarà presente, con un proprio stand, anche Life Episteme Italia che presenterà e dimostrerà  il dm MC-5A per la Scrambler Therapy ® .

SCRAMBLER THERAPY UN SISTEMA NON INVASIVO E SENZA EFFETTI COLLATERALI

MC-5A è un dispositivo medico (classe IIa), basato in esclusiva sul principio scientifico della Scrambler Therapy ®, per la Terapia del Dolore cronico ed oncologico, anche nei casi di resistenza agli oppiacei, di carattere prettamente ospedaliero ed ambulatoriale e anche domiciliare.

MC-5A simula 5 neuroni artificiali che, tramite elettrodi di superficie applicati sulla pelle e utilizzati per modulare correnti elettriche di bassissima intensità, sono in grado di inviare dei segnali che vengono identificati dal sistema nervoso centrale come segnali di “non dolore”.

La scomparsa del dolore è immediata, non è nota assuefazione; in seguito al ciclo di terapia gli effetti analgesici sono durevoli nel tempo.

La Scrambler Therapy ® è una terapia autonoma; non è richiesto alcun altro supporto analgesico in associazione.

MTS Medical Technology Solutions è rivenditore autorizzato Scrambler Therapy, per approfondimenti riguardanti pubblicazioni scientifiche, centri in Italia in cui è utilizzata la Scrambler Therapy, condizioni economiche e finanziamenti vi inviamo a contattarci

XXIV Congresso nazionale Società Italiana di Cure Palliative ultima modifica: 2017-11-03T10:25:41+00:00 da Stefano Bianchi
Scrambler Therapy

Corso gratuito per Scrambler Therapy

 

Sono aperte le iscrizioni al CORSO:
SCRAMBLER THERAPY – CAMPI DI APPLICAZIONE ED ESPERIENZE CLINICHE

che si terrà il 14 ottobre 2017

presso l’Aula Magna dell’ EUROPEAN HOSPITAL in Via Portuense nr. 700 a ROMA

Il corso è gratuito con iscrizione obbligatoria è da diritto a 4,3 Crediti ECM

PROGRAMMA

Ore 9,00 Iscrizioni

Ore 9,30 Dott. Riccardo Barchetta La ST e la  terapia del dolore : casi clinici ed esperienze sul dolore cronico benigno

Ore ‪11,00 Dott. Domenico Russo:  La ST in Hospice : casi clinici ed esperienze sui pazienti con dolore neuropatico e malattia neoplastica

Ore 12,00 Dott. Di Marcantonio: La ST per la riabilitazione funzionale: casi clinici ed esperienze su morbo di  sudeck e algodistrofia

Ore 13,00 Domande e discussioni (con la partecipazione del prof. Giuseppe Marineo)

Ore 14,30 Lunch

Scarica il pdf del modulo di iscrizione al link einvialo a questa mail

https://cloud.zenshare.it/lifeepistemeitalia/uploads/Moduli_iscrizione_corsi/171014scheda-iscrizione.pdf

MTS Medical Technology Solutions è rivenditore autorizzato Scrambler Therapy, per approfondimenti riguardanti pubblicazioni scientifiche, centri in Italia in cui è utilizzata la Scrambler Therapy, condizioni economiche e finanziamenti vi inviamo a contattarci

Corso gratuito per Scrambler Therapy ultima modifica: 2017-09-25T10:12:28+00:00 da Stefano Bianchi